Development and Validation of a Simple Diagnostic Tool Predictive of the Aseptic Character of Joint Effusion
PRASEPT
1 other identifier
observational
328
1 country
1
Brief Summary
Development and validation of a simple diagnostic tool predictive of the aseptic character of joint effusion in the primary care setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2019
CompletedFirst Posted
Study publicly available on registry
June 10, 2019
CompletedStudy Start
First participant enrolled
February 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedMarch 9, 2022
March 1, 2022
2 years
June 6, 2019
March 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of a septic arthritis
Presence of more than 2000 cells/mL and bacterial growth in the articular fluid.
10 days after the arthrocentesis.
Interventions
Arthrocentesis to determine the nature of the effusion (septic or aseptic).
Eligibility Criteria
All adult patients presenting with at least one clinical joint effusion accessible to arthrocentesis, interesting a native non operated joint, without any general antibiotic therapy in the previous 15 days.
You may qualify if:
- Adult patient (age ≥ 18 years)
- Hospitalized in the conventional hospitalization unit or day hospitalization unit or received in consultation within the Rheumatology or Infectious Diseases units at the Le Mans General Hospital
- presenting at least one joint effusion at clinical examination
- Interesting a native, nonoperated joint, accessible to a puncture based on clinical markers, determined by palpatory anatomy
- Affiliated to social security
- No opposition expressed after written information
You may not qualify if:
- General antibiotic therapy in progress or completed less than 15 days before
- Failure to perform the arthrocentesis
- Person subject to a legal protection measure, not allowing his compliance with the study
- Participant already included in another study (exclusivity clause)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Le Mans
Le Mans, 72 000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuelle Dernis, MD
Centre Hospitalier du Mans, Rheumatology Department
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2019
First Posted
June 10, 2019
Study Start
February 15, 2020
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
March 9, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share